Logo image of CRBN.AS

CORBION NV (CRBN.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:CRBN - NL0010583399 - Common Stock

19.09 EUR
-0.18 (-0.93%)
Last: 12/1/2025, 5:30:00 PM
Fundamental Rating

5

Taking everything into account, CRBN scores 5 out of 10 in our fundamental rating. CRBN was compared to 74 industry peers in the Chemicals industry. CRBN has only an average score on both its financial health and profitability. CRBN is valued quite cheap, but it does not seem to be growing. These ratings could make CRBN a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CRBN had positive earnings in the past year.
CRBN had a positive operating cash flow in the past year.
Each year in the past 5 years CRBN has been profitable.
Each year in the past 5 years CRBN had a positive operating cash flow.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.55%, CRBN is in the better half of the industry, outperforming 68.92% of the companies in the same industry.
CRBN has a Return On Equity of 9.12%. This is in the better half of the industry: CRBN outperforms 67.57% of its industry peers.
CRBN's Return On Invested Capital of 9.19% is fine compared to the rest of the industry. CRBN outperforms 75.68% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRBN is in line with the industry average of 6.87%.
The last Return On Invested Capital (9.19%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROIC 9.19%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CRBN (5.11%) is better than 64.86% of its industry peers.
In the last couple of years the Profit Margin of CRBN has grown nicely.
CRBN's Operating Margin of 8.68% is fine compared to the rest of the industry. CRBN outperforms 64.86% of its industry peers.
In the last couple of years the Operating Margin of CRBN has declined.
CRBN has a worse Gross Margin (26.10%) than 60.81% of its industry peers.
CRBN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CRBN has been reduced compared to 1 year ago.
Compared to 5 years ago, CRBN has less shares outstanding
CRBN has a better debt/assets ratio than last year.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CRBN has an Altman-Z score of 2.78. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.78, CRBN is in the better half of the industry, outperforming 64.86% of the companies in the same industry.
CRBN has a debt to FCF ratio of 4.95. This is a neutral value as CRBN would need 4.95 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.95, CRBN is in the better half of the industry, outperforming 74.32% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
CRBN has a Debt to Equity ratio (0.39) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Altman-Z 2.78
ROIC/WACC1.44
WACC6.37%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

CRBN has a Current Ratio of 1.21. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CRBN (1.21) is worse than 79.73% of its industry peers.
A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
The Quick ratio of CRBN (0.60) is worse than 87.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.99%.
Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
Looking at the last year, CRBN shows a small growth in Revenue. The Revenue has grown by 2.95% in the last year.
Measured over the past years, CRBN shows a small growth in Revenue. The Revenue has been growing by 5.70% on average per year.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

CRBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.24% yearly.
Based on estimates for the next years, CRBN will show a decrease in Revenue. The Revenue will decrease by -1.71% on average per year.
EPS Next Y36.6%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
EPS Next 5Y15.24%
Revenue Next Year-1.8%
Revenue Next 2Y0.45%
Revenue Next 3Y1.67%
Revenue Next 5Y-1.71%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.04 indicates a rather expensive valuation of CRBN.
CRBN's Price/Earnings ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 72.97% of the companies in the same industry.
When comparing the Price/Earnings ratio of CRBN to the average of the S&P500 Index (26.11), we can say CRBN is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 12.75, the valuation of CRBN can be described as correct.
CRBN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 70.27% of the companies in the same industry.
CRBN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.21.
Industry RankSector Rank
PE 17.04
Fwd PE 12.75
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

CRBN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 64.86% of the companies in the same industry.
CRBN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRBN is cheaper than 91.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.14
EV/EBITDA 7.99
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

CRBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
CRBN's earnings are expected to grow with 18.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.47
PEG (5Y)0.34
EPS Next 2Y21.96%
EPS Next 3Y18.01%

6

5. Dividend

5.1 Amount

CRBN has a Yearly Dividend Yield of 3.24%. Purely for dividend investing, there may be better candidates out there.
CRBN's Dividend Yield is a higher than the industry average which is at 3.13.
Compared to an average S&P500 Dividend Yield of 2.32, CRBN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.24%

5.2 History

The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

CRBN pays out 56.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.19%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CORBION NV

AMS:CRBN (12/1/2025, 5:30:00 PM)

19.09

-0.18 (-0.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31
Earnings (Next)N/A N/A
Inst Owners91.06%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.11B
Revenue(TTM)1.30B
Net Income(TTM)66.20M
Analysts77.14
Price Target23.33 (22.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.24%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.33%
PT rev (3m)-0.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-2.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-1.06%
Valuation
Industry RankSector Rank
PE 17.04
Fwd PE 12.75
P/S 0.86
P/FCF 11.14
P/OCF 6.6
P/B 1.53
P/tB 1.75
EV/EBITDA 7.99
EPS(TTM)1.12
EY5.87%
EPS(NY)1.5
Fwd EY7.84%
FCF(TTM)1.71
FCFY8.97%
OCF(TTM)2.89
OCFY15.15%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.47
PEG (5Y)0.34
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROCE 10.92%
ROIC 9.19%
ROICexc 9.57%
ROICexgc 10.55%
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
FCFM 7.7%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Debt/EBITDA 1.43
Cap/Depr 81.01%
Cap/Sales 5.3%
Interest Coverage 7.03
Cash Conversion 85.4%
Profit Quality 150.76%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.78
F-Score6
WACC6.37%
ROIC/WACC1.44
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.6%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-1.8%
Revenue Next 2Y0.45%
Revenue Next 3Y1.67%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year132.41%
EBIT Next 3Y36.9%
EBIT Next 5Y26.73%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


Can you provide the valuation status for CORBION NV?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CRBN stock?

The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 17.04 and the Price/Book (PB) ratio is 1.53.


Can you provide the dividend sustainability for CRBN stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.19%.